The International Expert Group on Biotechnology, Innovation and Intellectual Property undertook comprehensive case studies covering the most important and contentious issues in respect of biotechnology, innovation and intellectual property. These case studies are the most thorough and comprehensive analyses of the patenting of human genes, legislative change to permit the export of essential medicines, the protection of indigenous knowledge, business models to supply needed health products to developing countries and how one measures a country’s success in innovation.
- Myriad Genetics: In the Eye of the Policy Storm
- Respecting, Promoting, and Protecting Traditional Knowledge: A Comparative Case Study of Brazil, Kenya and Northern Canada
- Summary of Case Study (coming soon)
- Case Study (coming soon)
- Appendix 1 - Brazil (coming soon)
- Appendix 2 - Northern Canada (coming soon)
- Appendix 3 - Kenya (coming soon)
- Appendix 4 - Canadian Legislation
- Designing Metrics to Assess Impacts and Social Benefits of Publicly Funded Research in Health and Agricultural Biotechnology
- Governance Issues In Intellectual Property: The Jean Chretien Pledge To Africa Act
- A Model of Regulatory Burden in Technology Diffusion: The Case of Plant-Derived Vaccines
This work is licensed under a Creative Commons Licence.